One of our main focuses in 2017 was VS-CNV which allows clinicians to directly call CNVs in target regions quicker, easier and more affordably than CMA or MLPA testing. Our clients at Robarts Research Institute shared their recent publication with me which confirms that our time and dedication to our CNV capabilities was well worth it. I am delighted to… Read more »
First of all, I wish you a prosperous 2018 along with happiness and health for you and your loved ones. This next year comes with lots of anticipation. We at Golden Helix are looking forward to another year of growth and innovation. Over the last few years, we were able to build a large following of clients in the clinical space…. Read more »
It is a great honor for us to be recognized as one of the “Top 25 Biotechnology Solution Providers of 2017” by CIO Applications. You can find my interview with the editor here. We are incredibly thankful for the hundreds of organizations and thousands of users globally trusting our brand! Thank you for your support.
Golden Helix strives to enable precision medicine by developing powerful software that supports researchers with complex analysis. One of my favorite events of the year is our abstract competition that expands on our mission. This competition allows us to support our community by recognizing innovative ways to conduct genomic analysis. I am pleased to announce that our 2017-18 Abstract Competition… Read more »
We’ve returned from another successful year at ASHG and had an incredible time. I find the conference to be a terrific opportunity to connect with our customers, partners, and friends in the industry. This year’s Presidential Symposium was a true delight featuring a discussion of global health and genomics between two absolute legends in the health and science world: Bill Gates,… Read more »